Algert Global LLC Acquires New Position in Universal Health Services, Inc. $UHS

Key Points

• Algert Global LLC has acquired a new position in Universal Health Services, Inc., purchasing 2,770 shares valued at approximately $520,000 in the first quarter.
• Universal Health Services reported earnings of $5.35 per share for the recent quarter, surpassing analyst expectations; its revenue increased by 9.6% year-over-year.
• Wall Street analysts have mixed ratings on Universal Health Services, with targets for the stock ranging from $195 to $259, reflecting a consensus rating of "Hold."

Algert Global LLC acquired a new stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,770 shares of the health services provider's stock, valued at approximately $520,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. increased its holdings in Universal Health Services by 49.3% in the first quarter. UMB Bank n.a. now owns 203 shares of the health services provider's stock valued at $38,000 after buying an additional 67 shares during the last quarter. Coldstream Capital Management Inc. increased its holdings in Universal Health Services by 5.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 1,266 shares of the health services provider's stock valued at $227,000 after buying an additional 71 shares during the last quarter. MetLife Investment Management LLC increased its holdings in Universal Health Services by 0.5% in the fourth quarter. MetLife Investment Management LLC now owns 15,512 shares of the health services provider's stock valued at $2,783,000 after buying an additional 80 shares during the last quarter. HighTower Advisors LLC increased its holdings in Universal Health Services by 0.6% in the first quarter. HighTower Advisors LLC now owns 13,328 shares of the health services provider's stock valued at $2,504,000 after buying an additional 81 shares during the last quarter. Finally, IFP Advisors Inc increased its holdings in Universal Health Services by 6.7% in the first quarter. IFP Advisors Inc now owns 1,315 shares of the health services provider's stock valued at $247,000 after buying an additional 82 shares during the last quarter. 86.05% of the stock is owned by institutional investors.

Universal Health Services Stock Performance

Shares of NYSE UHS opened at $185.4380 on Monday. The company has a current ratio of 1.29, a quick ratio of 1.19 and a debt-to-equity ratio of 0.64. The stock has a 50 day simple moving average of $174.37 and a 200-day simple moving average of $178.43. The company has a market cap of $11.80 billion, a PE ratio of 9.77, a P/E/G ratio of 0.77 and a beta of 1.24. Universal Health Services, Inc. has a 12-month low of $152.33 and a 12-month high of $243.25.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The health services provider reported $5.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.85 by $0.50. The business had revenue of $4.28 billion during the quarter, compared to the consensus estimate of $4.24 billion. Universal Health Services had a return on equity of 18.25% and a net margin of 7.66%.The business's revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm posted $4.31 earnings per share. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. On average, equities research analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Universal Health Services Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Tuesday, September 2nd will be given a dividend of $0.20 per share. The ex-dividend date is Tuesday, September 2nd. This represents a $0.80 annualized dividend and a dividend yield of 0.4%. Universal Health Services's payout ratio is currently 4.21%.

Wall Street Analysts Forecast Growth

UHS has been the subject of several research analyst reports. UBS Group set a $227.00 price objective on Universal Health Services in a report on Wednesday, July 30th. Wall Street Zen upgraded Universal Health Services from a "buy" rating to a "strong-buy" rating in a research note on Saturday. JPMorgan Chase & Co. decreased their target price on Universal Health Services from $215.00 to $195.00 and set a "neutral" rating for the company in a research note on Monday, August 4th. Royal Bank Of Canada lifted their target price on Universal Health Services from $201.00 to $206.00 and gave the company a "sector perform" rating in a research note on Tuesday, August 19th. Finally, Barclays lifted their target price on Universal Health Services from $257.00 to $259.00 and gave the company an "overweight" rating in a research note on Wednesday, July 30th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $214.15.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.